and other services, travel costs and facility-related costs such as rent, utilities and other general office expenses. Results of Operations Comparisons of the Three Months Ended March 31, 2026 to the Three Months Ended March 31, 2025 Revenue .

filing / May 20, 2026 / receipt

(the “Board”) of the Company elected and appointed Vikram Grover as President, Chief Executive Officer, Chief Financial Officer,

filing / May 20, 2026 / receipt

Outsource manufacturing and regulatory capabilities. Bio-Path will not need to invest its resources in building functions where it does not add substantial value or differentiation.

ir_statement / Sep 15, 2026 / receipt

This should allow us to develop our drug candidates with experienced professional staff at a reduced cost compared to using external contract laboratories.

ir_statement / Sep 15, 2026 / receipt

This should also allow us to operate in an essentially virtual fashion, thereby avoiding the expense of setting up and operating laboratory facilities

ir_statement / Sep 15, 2026 / receipt

In July of 2011, the Company announced that it had relocated its corporate office to Houston, Texas.

ir_statement / Sep 15, 2026 / receipt

Our general and administrative expenses were $231,314 for the three months ended March 31, 2012; a decrease of $118,924 from the three months ended March 31, 2011.

ir_statement / Sep 15, 2026 / receipt

This decrease primarily results from a decrease in management salaries and stock option expense for the first quarter 2012 compared to the first quarter ending March 31, 2011.

ir_statement / Sep 15, 2026 / receipt